Patient Acceptable Percutaneous Coronary Intervention | Patient Acceptable Stenting
Item
must be an acceptable candidate for percutaneous coronary intervention, stenting, &
boolean
C0030705 (UMLS CUI [1,1])
C1879533 (UMLS CUI [1,2])
C1532338 (UMLS CUI [1,3])
C0030705 (UMLS CUI [2,1])
C1879533 (UMLS CUI [2,2])
C2348535 (UMLS CUI [2,3])
Patient Acceptable Emergency CABG
Item
emergent coronary artery bypass graft (cabg) surgery
boolean
C0030705 (UMLS CUI [1,1])
C1879533 (UMLS CUI [1,2])
C1532296 (UMLS CUI [1,3])
Myocardial Ischemia
Item
must have evidence of ischemic heart disease
boolean
C0151744 (UMLS CUI [1])
Target Lesion Single Amenable Stent | Target Lesion Quantity | Location Target vessel Separate | Target Lesion Amenable Stent
Item
must require treatment of either a) a single target lesion amenable to treatment with a 2.25 mm - 3.50 mm stent or b) two target lesions located in separate target vessels, with at least one of the target lesions amenable to treatment with a 2.25 mm- 3.50 mm mm study stent
boolean
C2986546 (UMLS CUI [1,1])
C0205171 (UMLS CUI [1,2])
C3900053 (UMLS CUI [1,3])
C0038257 (UMLS CUI [1,4])
C2986546 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C1515974 (UMLS CUI [3,1])
C0449618 (UMLS CUI [3,2])
C0443299 (UMLS CUI [3,3])
C2986546 (UMLS CUI [4,1])
C3900053 (UMLS CUI [4,2])
C0038257 (UMLS CUI [4,3])
Target Lesion de novo | Location Coronary artery Native
Item
target lesion(s) must be de novo lesion(s) in native coronary artery(ies)
boolean
C1521840 (UMLS CUI [1,1])
C0221198 (UMLS CUI [1,2])
C1515568 (UMLS CUI [1,3])
C1515974 (UMLS CUI [2,1])
C0205042 (UMLS CUI [2,2])
C0302891 (UMLS CUI [2,3])
Aspirin allergy | Medical contraindication Aspirin | Heparin allergy | Medical contraindication Heparin | Hypersensitivity Bivalirudin | Medical contraindication Bivalirudin | Hypersensitivity Thienopyridines | Medical contraindication Thienopyridines | Hypersensitivity Cobalt | Medical contraindication Cobalt | Allergy to nickel | Medical contraindication Nickel | Hypersensitivity Platinum | Medical contraindication Platinum | Hypersensitivity Iridium | Medical contraindication Iridium | Hypersensitivity Chromium | Medical contraindication Chromium | Hypersensitivity Molybdenum | Medical contraindication Molybdenum | Hypersensitivity Polymers Coating | Medical contraindication Polymers Coating | Contrast media allergy
Item
known hypersensitivity or contraindication to aspirin, heparin and bivalirudin, thienopyridines, cobalt, nickel, platinum, iridium, chromium, molybdenum, polymer coatings (e.g. biolinx) or a sensitivity to contrast media, which cannot be adequately pre-medicated
boolean
C0004058 (UMLS CUI [1])
C1301624 (UMLS CUI [2,1])
C0004057 (UMLS CUI [2,2])
C0571776 (UMLS CUI [3])
C1301624 (UMLS CUI [4,1])
C0019134 (UMLS CUI [4,2])
C0020517 (UMLS CUI [5,1])
C0168273 (UMLS CUI [5,2])
C1301624 (UMLS CUI [6,1])
C0168273 (UMLS CUI [6,2])
C0020517 (UMLS CUI [7,1])
C2936588 (UMLS CUI [7,2])
C1301624 (UMLS CUI [8,1])
C2936588 (UMLS CUI [8,2])
C0020517 (UMLS CUI [9,1])
C0009148 (UMLS CUI [9,2])
C1301624 (UMLS CUI [10,1])
C0009148 (UMLS CUI [10,2])
C1690547 (UMLS CUI [11])
C1301624 (UMLS CUI [12,1])
C0028013 (UMLS CUI [12,2])
C0020517 (UMLS CUI [13,1])
C0032207 (UMLS CUI [13,2])
C1301624 (UMLS CUI [14,1])
C0032207 (UMLS CUI [14,2])
C0020517 (UMLS CUI [15,1])
C0022071 (UMLS CUI [15,2])
C1301624 (UMLS CUI [16,1])
C0022071 (UMLS CUI [16,2])
C0020517 (UMLS CUI [17,1])
C0008574 (UMLS CUI [17,2])
C1301624 (UMLS CUI [18,1])
C0008574 (UMLS CUI [18,2])
C0020517 (UMLS CUI [19,1])
C0026402 (UMLS CUI [19,2])
C1301624 (UMLS CUI [20,1])
C0026402 (UMLS CUI [20,2])
C0020517 (UMLS CUI [21,1])
C0032521 (UMLS CUI [21,2])
C1522408 (UMLS CUI [21,3])
C1301624 (UMLS CUI [22,1])
C0032521 (UMLS CUI [22,2])
C1522408 (UMLS CUI [22,3])
C0570562 (UMLS CUI [23])
Allergic Reaction Zotarolimus | Hypersensitivity Zotarolimus | Allergic Reaction Sirolimus | Hypersensitivity Sirolimus | Allergic Reaction Tacrolimus | Hypersensitivity Tacrolimus | Allergic Reaction Everolimus | Hypersensitivity Everolimus | Allergic Reaction Analogue Any | Hypersensitivity Analogue Any | Allergic Reaction Derivative Any | Hypersensitivity Derivative Any
Item
history of an allergic reaction or significant sensitivity to drugs such as zotarolimus, rapamycin, tacrolimus, everolimus, or any other analogue or derivative
boolean
C1527304 (UMLS CUI [1,1])
C1700035 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C1700035 (UMLS CUI [2,2])
C1527304 (UMLS CUI [3,1])
C0072980 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C0072980 (UMLS CUI [4,2])
C1527304 (UMLS CUI [5,1])
C0085149 (UMLS CUI [5,2])
C0020517 (UMLS CUI [6,1])
C0085149 (UMLS CUI [6,2])
C1527304 (UMLS CUI [7,1])
C0541315 (UMLS CUI [7,2])
C0020517 (UMLS CUI [8,1])
C0541315 (UMLS CUI [8,2])
C1527304 (UMLS CUI [9,1])
C0243071 (UMLS CUI [9,2])
C1552551 (UMLS CUI [9,3])
C0020517 (UMLS CUI [10,1])
C0243071 (UMLS CUI [10,2])
C1552551 (UMLS CUI [10,3])
C1527304 (UMLS CUI [11,1])
C1527240 (UMLS CUI [11,2])
C1552551 (UMLS CUI [11,3])
C0020517 (UMLS CUI [12,1])
C1527240 (UMLS CUI [12,2])
C1552551 (UMLS CUI [12,3])
Cerebrovascular accident | Transient Ischemic Attack
Item
history of a stroke or transient ischemic attack (tia) within the prior 6 months
boolean
C0038454 (UMLS CUI [1])
C0007787 (UMLS CUI [2])
Peptic Ulcer | Upper gastrointestinal hemorrhage
Item
active peptic ulcer or upper gastrointestinal (gi) bleeding within the prior 6 months
boolean
C0030920 (UMLS CUI [1])
C0041909 (UMLS CUI [2])
Bleeding tendency | Blood Coagulation Disorders | Blood Transfusion Refused
Item
history of bleeding diathesis or coagulopathy or will refuse blood transfusions
boolean
C1458140 (UMLS CUI [1])
C0005779 (UMLS CUI [2])
C0005841 (UMLS CUI [3,1])
C1705116 (UMLS CUI [3,2])
Comorbidity | Life Expectancy
Item
concurrent medical condition with a life expectancy of less than 5 years
boolean
C0009488 (UMLS CUI [1])
C0023671 (UMLS CUI [2])
Study Subject Participation Status | Investigational New Drugs | Investigational Medical Device | End Point Primary Incomplete
Item
currently participating in an investigational drug or another device trial that has not completed the primary endpoint
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
C2346570 (UMLS CUI [3])
C2349179 (UMLS CUI [4,1])
C0205225 (UMLS CUI [4,2])
C0205257 (UMLS CUI [4,3])
Left ventricular ejection fraction
Item
documented left ventricular ejection fraction (lvef) < 30% at the most recent evaluation
boolean
C0428772 (UMLS CUI [1])